In vitro characterization of odorranalectin for peptide-based drug delivery across the blood–brain barrier

BACKGROUND: The use of siRNA-based gene silencing has been recently underscored as a potential therapeutic strategy for the treatment of neurological disorders. However, the stability of siRNA and other small molecule therapeutics is challenged by their intrinsic instability and limited passage acro...

Descripción completa

Detalles Bibliográficos
Autores principales: Sajja, Ravi K., Cudic, Predrag, Cucullo, Luca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6505199/
https://www.ncbi.nlm.nih.gov/pubmed/31068126
http://dx.doi.org/10.1186/s12868-019-0504-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6505199/
https://www.ncbi.nlm.nih.gov/pubmed/31068126
http://dx.doi.org/10.1186/s12868-019-0504-x

Ejemplares similares